Invesco Pharmaceuticals ETF
PJP
86 hedge funds and large institutions have $276M invested in Invesco Pharmaceuticals ETF in 2014 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 23 increasing their positions, 38 reducing their positions, and 9 closing their positions.
142% more call options, than puts
Call options by funds: $489K | Put options by funds: $202K
11% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 9
1% more funds holding
Funds holding: 85 → 86 (+1)
2.61% less ownership
Funds ownership: 26.28% → 23.68% (-2.6%)
9% less capital invested
Capital invested by funds: $303M → $276M (-$27.2M)
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
39% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 38
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIG
FundX Investment Group
San Francisco,
California
|
+$6.37M |
| 2 |
FMP
Financial Management Professionals
Austin,
Texas
|
+$3.24M |
| 3 |
Envestnet Asset Management
Chicago,
Illinois
|
+$2.53M |
| 4 |
UCFA
United Capital Financial Advisors
Irving,
Texas
|
+$2.32M |
| 5 |
B
Baird
Milwaukee,
Wisconsin
|
+$1.07M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$12.1M |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$8.67M |
| 3 |
PFG
Pacific Financial Group
Bellevue,
Washington
|
-$6.8M |
| 4 |
CM
Churchill Management
Los Angeles,
California
|
-$4.94M |
| 5 |
Morgan Stanley
New York
|
-$4.51M |
PJP Hedge Fund Activity: Q2 2014 in Review
86 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in Invesco Pharmaceuticals ETF (PJP) for Q2 2014, worth a combined $276M — down 9% from $303M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new PJP positions and 9 closed out — a net gain of 1 holder — while 23 added to existing stakes and 38 trimmed.
The largest buyer was FundX Investment Group, adding an estimated $6.37M. The largest seller was Goldman Sachs, cutting an estimated $12.1M.
- 86 institutional investors held Invesco Pharmaceuticals ETF (PJP) as of Q2 2014, up from 85 in Q1 2014.
- Funds reported $276M of Invesco Pharmaceuticals ETF stock for Q2 2014, down 9% quarter-over-quarter.
- 10 funds opened new Invesco Pharmaceuticals ETF positions in Q2 2014 and 9 closed out, a net change of +1 holder.
- The largest Invesco Pharmaceuticals ETF buyer in Q2 2014 was FundX Investment Group, an estimated $6.37M added.
- The largest Invesco Pharmaceuticals ETF seller in Q2 2014 was Goldman Sachs, an estimated $12.1M sold.
Based on aggregated 13F filings for Q2 2014.